Abstract

Purpose of ReviewPersistent genital arousal disorder (also referred to as genitopelvic dysesthesia or PGAD/GD) is a distressing and largely underrecognized condition characterized by persistent, unwanted genital arousal (sensations, sensitivity, vasocongestion) in the absence of subjective/cognitive arousal and sexual desire. The purpose of this review is to summarize recent findings on biological and psychosocial factors in PGAD/GD as they pertain to the assessment and treatment of this condition. These findings will be considered within a biopsychosocial framework, for the purposes of considering next steps for clinical and research efforts.Recent FindingsA small number of studies have recently examined potential biological aetiologies for PGAD/GD: pharmacological agents, spinal pathology and peripheral nerve involvement. Recent studies have also found that PGAD/GD is associated with a significant negative impact on psychosocial wellbeing and daily functioning as compared to symptom-free individuals. In addition, these results highlight cognitive/affective responses to symptoms (e.g. catastrophizing of symptoms) that may influence outcomes. However, biological and psychological research are rarely integrated in these studies, despite the interrelationship between these factors.SummaryAlthough PGAD/GD was first described in the scientific literature almost two decades ago, most research on PGAD/GD is presented in the form of case studies. Prospective treatment trials that integrate biopsychosocial factors are needed in order to provide effective and efficient care to this population. This research would be facilitated by the development of a patient-reported outcome measure, as well as greater education/awareness among healthcare providers and the public about this distressing condition.

Highlights

  • First described by Sandra Leiblum and Sharon Nathan in 2001, persistent genital arousal disorder is a highly distressing condition, characterized by genital arousal that occurs in the absence of subjective/cognitive arousal or sexual desire [1]

  • Given the similarities between PGAD and other forms of genitopelvic discomfort, it has been suggested that PGAD may be best considered a type of ‘genitopelvic dysesthesia’ where the primarily unwanted sensation is arousal [6, 8, 9]

  • We will refer to the condition as PGAD/genitopelvic dysesthesia (PGAD/GD)

Read more

Summary

Introduction

First described by Sandra Leiblum and Sharon Nathan in 2001, persistent genital arousal disorder (or PGAD) is a highly distressing condition, characterized by genital arousal (e.g. genital sensations, sensitivity and/or vasocongestion) that occurs in the absence of subjective/cognitive arousal or sexual desire [1].

Topical Collection on Female Sexual Dysfunction and Disorder
Biological Factors in PGAD
Pharmacological Causes and Interventions
Spinal Pathology
Future Research and Clinical Considerations
Findings
Compliance with Ethical Standards
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.